Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Primaquine Regimens with DHA-P or Chloroquine for Vivax Malaria
NCT01640574Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Feb 2012
- Primary completion
- Jul 2015
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine in Plasmodium vivax malaria, sponsored by University of Oxford. Started Feb 2012; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT01640574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01640574.